Mayo Clinic

Mayo Clinic experts to help guide Delta Air Lines COVID-19 safety measures

Industry leaders in health and travel formalize partnership to transform the future of safe flying

ROCHESTER, Minn. — Delta Air Lines and Mayo Clinic, a global leader in serious and complex medical care, are deepening their relationship to provide additional safety and COVID-19 infection control measures for customers and employees. The collaboration is another significant step in Delta’s efforts to build upon its foundation of care and cleanliness, known as the Delta CareStandard, to mitigate the risk of transmitting COVID-19 during travel.

"There’s nothing more important than the health and safety of our people and our customers. As we continue adjusting our business to mitigate the risk of COVID-19 transmission, there’s no organization in the world better equipped than the Mayo Clinic to act as Delta’s medical advisor," says Ed Bastian, CEO – Delta Air Lines. "The role Mayo will play in testing our employees and advising on safety practices at airports and work spaces will help deliver the additional layers of protection needed to safeguard our customers and employees."

The Delta CareStandard layers of protection, along with other measures that protect employees, in part contributed to a significant decrease in the number of employees testing positive for COVID-19 between April and May. Since May, the number of employees testing positive is well below the national average. Delta is working closely with expert advisors at Mayo Clinic to review, enhance and continuously improve health and safety protocols.

"The health and safety of employees and customers continues to be our priority during this time of unprecedented uncertainty," says Gianrico Farrugia, M.D., president and chief executive officer, Mayo Clinic. "Mayo Clinic’s expertise in infection prevention and control, as well as our research on COVID-19, provides us with expert insight to support Delta through advisory services, helping to implement best practices to mitigate the spread of COVID-19."

Delta Air Lines will consult with Mayo Clinic on the following:    

  • COVID-19 Testing for Full Delta Workforce – As one of the first Fortune 100 companies to embark on COVID-19 testing for its entire workforce, Delta views testing as a critical step in protecting the health and safety of employees and customers. Mayo Clinic Laboratories has designed Delta’s employee testing program, assisted in administering diagnostic and serology tests, and will analyze the findings to determine broader trends. Based on the findings, Mayo Clinic will provide recommendations to Delta’s existing policies and procedures, perform workforce risk assessments and review re-testing programs for the ongoing safety of Delta people.
  • Establish an Integrated Advisory Council – Comprised of professionals from both organizations, this executive team will meet frequently to review and assess Delta’s health and safety policies and procedures. Mayo Clinic will also provide Delta with ongoing clinical guidance to help mitigate the spread of COVID-19 through enhanced safety measures for employees. This council will be co-led by Rob Kight, senior vice president of Human Relations at Delta, and Henry Ting, M.D., chief value officer at Mayo Clinic, and William Morice II, M.D., Ph.D., president of Mayo Clinic Laboratories.
  • Customer Health Consulting – Working closely with Delta’s Customer Experience team under the guidance of Bill Lentsch, chief customer experience officer, Mayo Clinic will review and provide guidance on current customer-facing protocols and safeguards in place, and provide counsel on how to enhance these measures for optimal results. In addition, Mayo Clinic will advise Delta on best practices for customers regarding COVID-19 prevention, including the use of effective personal protective equipment, and guidance on how Delta can continue to provide a safe and clean travel experience.

"Satisfaction scores among Delta travelers have been at an all-time high during the pandemic, but as more customers return to travel, we understand they’ll need even greater assurances that Delta experiences are safe,” says Lentsch. “This is a journey with no finish line – and we know that more than three quarters of customers, when asked, share that regular employee testing will help boost their confidence in travel. This is the foundation upon which we will innovate and redefine future travel experiences that ensure we are delivering the safe experiences our customers expect and deserve."

"Mayo Clinic has responded to the COVID-19 pandemic by developing innovations in molecular and antibody testing, therapies including convalescent plasma, and protocols and procedures to protect our staff and patients from the spread of infection," says Dr. Ting. "We look forward to collaborating with Delta by using advanced analytics and ongoing testing innovations to help their passengers travel as safely as possible."

Media contact: Ginger Plumbo, Mayo Clinic Public Affairs, [email protected]

###

About Delta Air Lines
Delta Air Lines (NYSE: DAL) is the U.S. global airline leader in safety, innovation, reliability and customer experience. Powered by our employees around the world, Delta has for a decade led the airline industry in operational excellence while maintaining our reputation for award-winning customer service.

Today, and always, nothing is more important than the health and safety of our customers and employees. Since the onset of the COVID-19 pandemic, Delta has moved quickly to transform the industry standard of clean while offering customers more space across the travel journey. These and numerous other layers of protection ensure a safe and comfortable travel experience for our customers and employees.

With our mission of connecting the people and cultures of the globe, Delta strives to foster understanding across a diverse world and serve as a force for social good. Read more about Delta.

About Mayo Clinic
Mayo Clinic is a nonprofit organization committed to innovation in clinical practice, education and research, and providing compassion, expertise and answers to everyone who needs healing. Visit the Mayo Clinic News Network for additional Mayo Clinic news and Mayo Clinic Facts for more information about Mayo.



Filters close

Showing results

1120 of 5827
Newswise: For Transplant Recipients, Third Time May Be the Charm for Better COVID Vaccine Protection
Released: 14-Jun-2021 5:15 PM EDT
For Transplant Recipients, Third Time May Be the Charm for Better COVID Vaccine Protection
Johns Hopkins Medicine

In a study published today in the Annals of Internal Medicine, Johns Hopkins Medicine researchers say they believe that, for the first time, there is evidence to show that three doses of vaccine increase antibody levels against SARS-CoV-2 — the virus that causes COVID 19 — more than the standard two-dose regimen for people who have received solid organ transplants.

Newswise: Broadway1_DTLA_sz.lowres-768x512.jpg
Released: 14-Jun-2021 4:05 PM EDT
What’s Next: The Ongoing Urban Exodus
University of California, Irvine

Many employees have come to prefer working from home after being forced to do so more than a year ago when the pandemic started. By some estimates, at least one-quarter of employees will still be working remotely multiple days a week at the end of 2021. For those whose jobs allow it, being untethered from the office might mean moving farther away from it – by a few miles or a few hundred.

Newswise: 267701_web.jpg
Released: 14-Jun-2021 2:50 PM EDT
New model accounts for the effect of behavior changes to predict COVID-19 cases
Brown University

By adding behavioral components to an infectious disease model, Brown University researchers have developed a new modeling approach that captures the peaks and valleys in new COVID-19 cases seen over the past 16 months.

Newswise: Masking, breakthrough infections and telehealth: Keck Medicine of USC experts on life after June 15
Released: 14-Jun-2021 2:05 PM EDT
Masking, breakthrough infections and telehealth: Keck Medicine of USC experts on life after June 15
Keck Medicine of USC

June 15 is a banner day in California. Most COVID-19 statewide restrictions will be eliminated, including physical distancing and in many situations, mask mandates. How will life change and how will it stay the same? Keck Medicine of USC experts weigh in on what to expect next in the golden state.

Newswise: California Reopening: Experts Say Keep Masks Handy
Released: 14-Jun-2021 10:35 AM EDT
California Reopening: Experts Say Keep Masks Handy
Cedars-Sinai

This week brings a milestone to pandemic-weary Californians: As of June 15, California public health guidelines that have been in place during the 15 months of the COVID-19 pandemic will be relaxed. Those who are fully vaccinated against COVID-19 will be able to go mask-free in most situations, but Cedars-Sinai infectious disease experts suggest masks, an important tool in preventing transmission of the virus, will be with us a while longer.

Released: 14-Jun-2021 9:45 AM EDT
People with Health Insurance Vaccinated More Than Those Without, Survey Finds
Rutgers University-New Brunswick

People with health insurance are receiving the COVID-19 vaccine at a higher rate than those without insurance, despite the vaccine being free, according to a national survey from the Edward J. Bloustein School of Planning and Public Policy at Rutgers University-New Brunswick.

Newswise:Video Embedded study-links-covid-19-public-health-efforts-to-dramatic-drop-in-copd-hospitalizations
VIDEO
Released: 14-Jun-2021 8:00 AM EDT
Study Links COVID-19 Public Health Efforts to Dramatic Drop in COPD Hospitalizations
University of Maryland Medical Center

Public health measures designed to reduce the spread of the COVID-19 virus may have fostered a substantial side benefit: A 53 percent drop in hospital admissions for chronic obstructive pulmonary disease (COPD), likely due to a drop in circulating seasonal respiratory viruses such as influenza.

access_time Embargo lifts in 2 days
Embargo will expire: 20-Jun-2021 9:00 AM EDT Released to reporters: 13-Jun-2021 1:05 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 20-Jun-2021 9:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

access_time Embargo lifts in 2 days
Embargo will expire: 20-Jun-2021 9:00 AM EDT Released to reporters: 13-Jun-2021 12:05 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 20-Jun-2021 9:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: 267646_web.jpg
Released: 11-Jun-2021 2:10 PM EDT
Saliva can be more effective than nasopharyngeal swabs for COVID-19 testing
Elsevier

The collection of nasopharyngeal swab (NPS) samples for COVID-19 diagnostic testing poses challenges including exposure risk to healthcare workers and supply chain constraints.


Showing results

1120 of 5827

close
1.6954